iiinova — where your digital self keeps evolving

Reposted by European Lobular Breast Cancer Consortium

Lobular Breast Cancer Alliance (LBCA) @lobularbca.bsky.social · 07/02/2025

The Lobular Breast Cancer Alliance has joined Bluesky! Follow us here for information about the 2nd most common type of breast cancer, invasive lobular carcinoma (ILC). More coming soon! www.lobularbreastcancer.org

lobularbreastcancer.org

Lobular Breast Cancer Alliance (LBCA)

Patients, researchers and clinicians working together to advance research and promote better prevention, diagnosis, treatment and follow-up care for invasive lobular breast cancer (ILC).

1154

Reposted by European Lobular Breast Cancer Consortium

George Sflomos @georgesflomos.bsky.social · 22/03/2025

Wonderful presentations from a truly inspiring #Lobular Breast Cancer Symposium 2024 in Leuven! Happy viewing! #CDH1 #ILC #TME #ImmunoILC #LOXL1 @elbcc-2018.bsky.social www.youtube.com/watch?v=g7IN... www.youtube.com/watch?v=g7IN... www.youtube.com/watch?v=P56x... www.youtube.com/watch?v=rOLa...

youtube.com

ILC Symposium 2024 - Day 1 - 9/23/2024

YouTube video by Invasive Lobular Breast Cancer (ILC) Symposium

041

Reposted by European Lobular Breast Cancer Consortium

Patrick Derksen @pwbderksen.bsky.social · 07/03/2025

Afadin is an #ILC #metastasis suppressor! Based on clinical and experimental data we show that Afadin inhibits metastasis by stabilizing the #E-cadherin to F-actin link. The α-catenin binding CC domains is key, not the F-actin binding region! pathsocjournals.onlinelibrary.wiley.com/doi/10.1002/...

052

European Lobular Breast Cancer Consortium @elbcc-2018.bsky.social · 27/02/2025

We have overhauled www.elbcc.org and ask all existing and future participants to register and indicate their preferred working groups. Check the site, current members, and spread the word! @christinedesmedt.bsky.social @pwbderksen.bsky.social @lobularbcuk.bsky.social @lobularbca.bsky.social

058